Urgent warning to Frankston South residents to stop drinking ‘contaminated' tap water
On Sunday, South East Water issued a boil water advisory to residents in parts of Frankston South after the tap water was found not safe for drinking.
Residents in the boundaries of Baden Powell Drive back to the foreshore, between Humphries Rd and Violet St, are affected by the drop in water pressure.
Affected customers have been notified via SMS and email, SE Water said in a statement.
The warning was issued due to a drop in water pressure in the Frankston South network that can cause dirty water and sediment to flow through the pipes.
'When water pressure is low, it means the water isn't flowing strongly through the pipes,' the company said.
Until the issue has been sorted, residents have been told to boil their tap water before consuming it to kill all bacteria and contaminants that may be inside.
Those who have ingested the water may experience gastro-like symptoms, including diarrhoea, nausea, vomiting and stomach cramps.
'While we undertake some water testing and investigations, we've issued this advisory to make sure the local tap water is safe to drink,' the SE Water statement read.
'We're advising you to boil your water before drinking, mixing cold beverages, preparing food, making ice, brushing teeth and gargling.'
Families have been advised to sponge-bath their babies and toddlers to prevent them from swallowing water.
'It's still safe to use unboiled water to flush toilets, wash dishes and clothes, and water the garden,' the statement read.
Pet owners have also been advised to provide cooled-down boiled water until the boil water advisory has been lifted.
Residents have been told water filter systems will not make the tap water safe to drink, as they are 'not designed to remove microbiological contamination from an unsafe water supply'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
a minute ago
- News.com.au
Assistive tech targets market growth while improving lives
Demand for assistive technologies on the rise with growing global ageing population and awareness of disability inclusion Cochlear one of most high-profile ASX assistive technologies companies with legacy spanning more than 40 years Control Bionics helping thousands around the world communicate and connect in ways once thought impossible With a rising global ageing population and awareness of disability inclusion growing, demand is increasing for technologies that help people maintain independence and improve quality of life. Assistive technologies go beyond medical diagnostics or treatment by directly enabling individuals to hear, see, communicate and perform daily activities they might otherwise struggle to do. And while assistive technology delivers clear social benefits and aligns with ESG goals, it's also targeting a rapidly expanding market. Globally the assistive tech market was valued at ~US$22.9 billion in 2023 and is projected to reach US%36.6 bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.8% throughout the decade. In Australia, the assistive technology sector is projected to expand from ~US$720 million in 2023 to more than US$1.7bn by 2030, driven by demographic shifts such as an ageing population and rising prevalence of long-term disabilities. Australia's substantial healthcare expenditure is also considered a pivotal driver for demand in the Australian disabled and elderly assistive device market. Global pioneer in hearing implant technology From restoring communication for those with severe disabilities to preserving vision and enhancing hearing, Australian companies have a proud history in assistive technologies with ASX blue-chip Cochlear (ASX:COH) one of the most high profile. Cochlear stands as one of the world's foremost innovators in assistive hearing technology with a legacy spanning more than 40 years. Cochlear implants and bone conduction devices are life-changing products, which have enabled hundreds of thousands of people globally across all ages to hear and communicate more effectively. Cochlear CEO and president Dig Howitt told Stockhead the organisation continued to progress new technology and care models, having recently launched the Cochlear Nucleus Nexa System, the world's first and only smart implant system. "The Nucleus Nexa Implant is the outcome of a 20 year investment in R&D and is the first cochlear implant to run its own firmware," he said. Howitt said similar to smartphones, the implant firmware could be updated to enable new features and access future innovations. "Recipients will now have access to a better hearing experience with both implant and sound processor updates," he said. "The Nucleus Nexa System builds upon Cochlear's industry-leading portfolio of electrodes, which are designed to optimise the electrode-neural interface and protect cochlea health and opens the door to even greater hearing potential for patients into the future." Enhancing sound in real-world situations While Cochlear may dominate the implantable hearing device market Brisbane-based Audeara (ASX:AUA) is carving out its own space in personalised listening solutions that sit between consumer audio products and clinical hearing aids. The flagship Audeara headphones and TV bundles the company started with use built-in hearing checks to create tailored sound profiles, ensuring clearer, enhanced listening experiences. Audeara managing director James Fielding told Stockhead the features made the devices valuable for those with mild to moderate hearing loss, or for people using cochlear implants and hearing aids who got an incredible entertainment experience when the sound was tailored to their needs. Building its portfolio Audeara launched Buds into its clinic networks this year. Unlike conventional hearing aids, Buds focus on enhancing the sound in real world situations like a busy cafe while also staying true to their entertainment focus, enhancing calls, TV and music. "We believe assistive technology should enhance the human experience without compromise," Fielding said. "At Audeara, our personalised hearing solutions empower people to connect more deeply with music, conversations and entertainment, regardless of their hearing ability." The technology also supports accessibility through government funding programs including NDIS, DVA and the Hearing Services Program, broadening its reach and affordability. With distribution in 1,500 clinics across Australia and more than 3,000 globally, including partnerships with major networks like Specsavers and Amplifon, Audeara is well positioned to capture growth in a market that's both socially impactful and commercially attractive. "The future of assistive technology is about inclusion, not limitation," Fielding said. "Audeara's mission is to ensure that hearing health solutions are seamlessly integrated into everyday life, combining clinical credibility with consumer-level accessibility." 'Giving communication back for more than two decades' Control Bionics (ASX:CBL) CEO Jeremy Steele describes the assistive technology medical device company as "sitting at the intersection of neuroscience and accessibility". "For more than 20 years, Control Bionics has been at the forefront of assistive technology innovation, helping thousands of people around the world communicate and connect in ways once thought impossible," Steele told Stockhead. Control Bionics has developed the NeuroNode – a wearable, watch-like, wireless non-invasive electromyography (EMG) and spatial sensor device to assist cognitive people with physical disabilities perform everyday functions. He said NeuroNode was globally unique as the only augmentative and alternative communication (AAC) technology of its kind that combined movement and EMG signals into a single platform. "Recognition by the US Centers for Medicare & Medicaid Services, awarding NeuroNode the first HCPCS code for an AAC device in 13 years, validates both the technology and the profound impact it delivers," he said. "We're proud to be a pioneer in the fast-emerging neurotechnology space, empowering people living with conditions like ALS, cerebral palsy and spinal cord injury to reclaim their voice and their independence." Steele said the company's objective was simple but ambitious – to expand global access to the most advanced, intuitive and life-changing assistive technologies available today. "The NeuroNode isn't just a device, it's a lifeline to communication, control and connection," he said. "We believe that every person – regardless of physical ability — deserves a way to engage with the world. "Our team's work over two decades reflects a deep commitment to designing technologies that break through barriers and restore possibility."
News.com.au
28 minutes ago
- News.com.au
How Australia is failing dying children
EXCLUSIVE Warning: This story discusses the death of a child and paediatric palliative care Looking back now, 51-year-old Alix can see the signs that her irreverent, curious youngest child, Sofia, was seriously ill much earlier than anyone realised. In early 2018, the six-year-old was getting headaches. Somewhat inexplicably – given Sofia's happy and relaxed family and school life – the doctors put the issue down to 'stress'. Only when Alix, her husband and their eldest daughter holidayed with Sofia in Bali later that year did things become impossible to ignore. To Alix, Sofia seemed unusually thin, and her stomach was swollen. On their return to Australia, an ultrasound revealed the devastating truth. 'That's when our lives changed, you know? The doctor phoned me to say I had to come to the clinic immediately. Sofia had a tumour in her tummy, in her liver,' Alix told The diagnosis was angiosarcoma, a rare and aggressive cancer usually seen in adults, not young children. The prognosis was grim. Sofia's story is far from unique. In Australia, approximately 32,000 children live with life-limiting conditions. Yet, according to the Australian Institute of Health and Welfare, in 2021 alone, an estimated 654 children died from these conditions, and less than half received specialist paediatric palliative care. Palliative care is specialised medical support for people with life-limiting illnesses, focused on improving quality of life rather than prolonging it. Yet despite its benefits, many families of critically ill children are never offered this care — a gap experts say must urgently be addressed. In the wake of Sofia's diagnosis, what followed were months of surgeries, chemotherapy, radiotherapy, and unrelenting uncertainty. At one stage, doctors removed a vertebra from Sofia's spine and replaced it with titanium. The young girl, once so lively and full of energy, woke from surgery unable to walk, plagued by burning sensations and neurological issues. 'When you talk about the treatment, that's what hurts the most,' Alix says, her voice faltering with grief as she recalls the needles, the fever, the feeding tube. 'That is the part that becomes difficult.' For a while, Sofia returned to school. But the cancer came back, this time in her foot and hip. The doctors understood Sofia would not survive. 'They knew she would die but they didn't tell us: 'This is the path.' 'Communication was absent,' Alix explained. Instead, a cycle of vague suggestions for further chemotherapy and radiotherapy continued, even after it was clear Sofia's cancer was terminal. Alix remembers the moment she and her husband were encouraged to consider yet more treatment. 'We couldn't understand. If she's going to die and the cancer is going to keep growing, why are you offering her chemo and radio,' she said. The family had reached breaking point. 'We didn't want to be disrespectful, but we wanted to scream at the doctor and say: 'Are you stupid? Why do you want her to have that?' So, she's going to last six more months and she will die, vomiting, bald, not eating and with a tube. Horrible!' In that moment, Alix did something many parents never feel empowered to do. She took a deep breath and asked for something radically different. 'I said, 'When the time comes, can you help her to die well? I don't want her to suffer.'' Only then, after Alix specifically requested it, was Sofia referred to specialist palliative care services. This delay is heartbreakingly common, according to experts like Sara Fleming, an Adelaide-based nurse practitioner with nearly 25 years' experience in paediatric palliative care. 'The most heartbreaking thing that used to happen, and sometimes still does, is when referrals come late, and a family would sit there asking, 'Where have you been? Why didn't we meet you before?'' Sara recalls her early days in the sector when families with dying children were left isolated, afraid, and unsupported. 'There was a level of suffering that didn't need to be there, just because of a lack of knowledge and a lack of outreach from health professionals.' In the wider community, families face social isolation too. Friends, neighbours and acquaintances often don't know how to cope, so they simply disappear. 'You represent the unthinkable,' Sara says. 'These diagnoses, these things that kill people's kids … it's generally just a s**tful roll of the dice. And so, you reflect, 'There by the grace of God, goes me.'' Alix experienced this first-hand. 'When a kid gets sick, everyone is so panicked, and people don't talk to you anymore because they don't know how to manage,' she explained. Yet, as Alix and experts like Sara argue, early, honest conversations about prognosis, treatment options, and palliative care could dramatically change families' experiences. Sara believes paediatric palliative care is fundamentally different from end-of-life care for adults. Children often live with life-limiting conditions for years, while still navigating normal developmental challenges like puberty, friendships and schooling. 'We're stepping into working alongside a family where their child has been diagnosed with a life-limiting illness or disease,' she said, 'However, in the meantime, what matters is the living of that life. For children, it's also about what happens after they die. 'What memories or mark will they leave behind? For kids, it's important that we have these conversations about what's their legacy.' Alix's daughter Sofia was a perfect example of this. 'She was always laughing, even since she was four months old. She was so much fun, and even when she grew up, she was always cheeky.' Sofia loved to paint, read, and collect rocks. Her bedroom is still filled with soft toys, books, and her framed artwork. 'Rocks?' I ask Alix, surprised. Alix nods, laughing softly through tears. 'She used to pick them up and bring them to the house. And I used to throw them away so much! She was a different [type of] person, and she would speak up her mind.' In Sofia's final months, Alix kept her promise: no more needles, no more invasive treatments. Her pain was managed, and she was surrounded by loved ones. The night before she died, Sofia's family gathered for a prayer. Alix whispered gently to her: 'When you dream, just follow the light, because you're going to be happy again. You're going to run again.' Sofia died at home on June 7, 2020. For Alix, one of the most painful parts of the experience remains the absence of clear, compassionate conversations from medical professionals early in Sofia's diagnosis. 'Don't make people suffer because you don't want people to die. It's not your job to save everyone,' she said. Her message echoes what advocates have been fighting for decades to achieve: a health system where families like hers aren't left to fend for themselves, and where palliative care is offered early, not as a last resort. A national first for Australia, the Paediatric Palliative Care National Action Plan is aiming to shift that reality. Released in 2023 by Palliative Care Australia (PCA) after years of research and consultation, the Plan marks a significant step forward for Australian families and health professionals. Now in its second stage, PCA is working on nationwide awareness and implementation. 'This is a really important step for paediatric palliative care in Australia,' Annette Vickery, Projects Manager at PCA, told 'Having a national plan and clear guidelines means families and clinicians will finally have more consistency and support. I hope it makes a real difference in everyday practice — helping teams feel more confident and better equipped to care for children, wherever they are.' The Plan has also led to the development of Australia's first paediatric palliative care clinical guidelines – which will be made public by the end of this year – as well as the nation's first Paediatric End-of-Life Care Communication course for health professionals. This whole suite of work was co-designed with bereaved parents. 'Talking and communicating a terminal diagnosis is difficult and especially so when it involves children and young people,' Annette explained. 'It was very important that we equip and empower our health professionals with the right skills and tools to communicate meaningfully across different stages of the care journey and across diverse cultures.' But Annette is clear: there is still a long way to go. 'Too many children who could benefit from paediatric palliative care are not referred early enough,' she said. 'Systemic barriers like workforce shortages, lack of community-based services, lack of connections between specialists, and the stigma attached to the term 'palliative care' often delay or limit access.' The Plan specifically acknowledges the inequities faced by families outside major cities, those from disadvantaged backgrounds, and children with non-cancer conditions — groups who often miss out on timely care altogether. To tackle this, the Plan recommends workforce training, culturally safe care, and expanding outreach services, including for families in rural and remote areas. Annette also believes it's about reframing how society understands palliative care. 'When palliative care is seen only as end-of-life care, families and health professionals often delay referrals, fearing it means giving up hope,' she explained. 'What's lost is the chance to make memories, and spend the last days, months or years doing what matters most with your loved ones.' For Sara, it's time for the health workforce to face the uncomfortable truth. 'It's about the clinician saying, 'This is not a failure.' It's not a failure to acknowledge that maybe time might be short.' Her hope, like Alix's, is for a cultural shift — one that finally brings children's palliative care out of the shadows. 'If we start teaching kids about death, since they are little, they will take it as natural from childhood into adulthood,' Alix added. And, perhaps, families like hers will no longer have to navigate the unimaginable alone. For anyone seeking further information and resources about paediatric palliative care, start here.
ABC News
31 minutes ago
- ABC News
Quest for agelessness drives longevity boom — and $2.5 trillion global industry
It's a characteristically chilly Melbourne winter morning and tech boss Tristan Sternson is starting the day by plunging into an ice bath. Just how icy? A bone-chilling 3 degrees Celsius — for 4 minutes. Next follows a "strict routine" of exercise, supplements, IV infusions and various treatments like saunas, cryotherapy, hyperbaric oxygen therapy … all in his quest to feel better and live longer. "Things like cryotherapy, which is minus 165C in a cryotherapy chamber for three and a half minutes, which is quite extreme," he tells The Business from the longevity clinic he co-founded and where he partakes in many of the treatments. "I do red light in a full body machine where you lie down. Kind of like a cocoon. "Red light [is also good] for your hair to make sure your hair doesn't thin as you get older." Mr Sternson admits his wellness club, Super Young, is more of a passion project than anything. "My wife will call it an obsession," he said. Mr Sternson is 45 but says he has a "biological age" of 34 — a metric used by those in the longevity space based on a series of tests. He tracks 65 different markers via blood tests and completes a range of what he calls more "extreme" treatments every few months, some of which he flies to the US for as they are not available in Australia: Super Young is one of many health and wellness businesses vying for a slice of what consulting firm McKinsey says is a $2.5 trillion global consumer wellness industry. It's driven by a growing demand from (often wealthy) individuals to measure and optimise personal health — and a willingness to pay big bucks to do so. The "preventative wellness" or longevity movement's signature alternative health practices have been popularised by US figures including biohackers Bryan Johnson, Peter Attia and even socialite Paris Hilton. It grew in the wellness heartland of Los Angeles and has since spread to Australia. The growing popularity of ice baths and infrared saunas Down Under has made them a more common sight in gyms and spas in the wealthier enclaves of many cities. The explosion of an industry full of alternative health practices has been met with scepticism by some in mainstream medical fields. "I think the evidence base for a lot of them is minimal and, where there is evidence, it's often for particular parts of the population and not for the general population," the president of the Royal Australian College of General Practitioners, Michael Wright, tells The Business. For those who want to dip their toes in the longevity pool, Dr Wright advises a healthy dose of scepticism and careful thought before doing extra tests or investigations clinics might offer. "I often talk to patients when they are talking about these tests and ask them, 'What's the cost of this?' and, 'Who is most likely to benefit? Is it you or is it the person who is selling the test?'" He notes the principle in medicine of "first, do no harm" and questions whether the extensive blood work and diagnostic tests often associated with longevity screening and measurement fit that bill. "Potentially, if you're investigating unnecessarily, you're putting people through stress and also economic impacts if the tests are unnecessary and that's something we should try and avoid," he said. But Mr Sternson says the treatments at his wellness hub are backed by evidence and there is strong demand from consumers willing to pay for detailed analysis of their health and personalised programs. "Each machine or each protocol that we have, every supplement that we offer, will have some research back behind it," he argues. But he does acknowledge the difficulty of establishing evidence given "you haven't had anyone live to 150 that's gone through these sorts of protocols". Another Australian company riding the trillion-dollar wellness wave is high-profile startup Eucalyptus, which launched a longevity app for men last year. They pulled the pin soon after, with the pricey subscription fee a major factor, but are hoping to relaunch in Australia next year at a lower cost with more automation. "What we learnt was that patients really had a curiosity about their own diagnostics, were really keen to make behavioural change," Eucalyptus chief executive and co-founder Tim Doyle explains in an interview with ABC News. The company, which is backed by Woolworths and Blackbird, runs a suite of health platforms and has grown rapidly — largely thanks to the rise of its weight-loss service, which enables users to access drugs like Ozempic via a telehealth app. Mr Doyle says Eucalyptus's digital platform made the experience of prescribing the drugs to patients seamless. "People are seeking convenience, quality of care, in a way that suits their lifestyle and so I think what we've been able to tap into is the evolving trends there," he said. Ozempic and similar prescription weight-loss drugs shot to prominence over the past few years and Eucalyptus has become a major player in the weight-loss market thanks to its provision of those drugs. "I think we're an evolution of where health care will definitely go," Mr Doyle said. Mr Doyle said more than 100,000 customers globally had accessed the weight-loss drugs through the company. "I think ultimately these medications are going to change the world for the better," he asserts. "We provide a set of services that give you the best chance of hitting your weight-loss goal and maintaining weight loss and I think the reality is that for most patients that are suffering with obesity, there are serious health considerations for that." However, medical bodies have been critical of the app's online prescription model for pharmaceuticals. "We do have to be really careful of other providers who are potentially fragmenting care, because it's important that whoever else you see in the health system that they confirm and share information with your usual GP," the RACGP's Dr Wright said. "There's no substitute for the quality of care that you get from a GP who knows you and your history. So although these other services are available, they don't replace what you should get and what you can get from your GP. "I think that's a fair criticism," Mr Doyle acknowledges, though he notes that "a lot of patients don't have a regular relationship with a standard GP that they live their whole lives with. Like Eucalyptus, Super Young's co-founder said they were not trying to compete with established medicine but offer something different, without adding an extra burden or cost to publicly funded healthcare. "We're kind of an adjunct. We help out and we can kind of take the strain off it a little bit, because you can help people prevent certain illnesses," Mr Sternson says. "I don't think we're disrupting the current healthcare system … the current healthcare system is really, really good when you're sick. He says the industry can cater for well individuals willing to pay money for testing privately to optimise their health, rather than go through Medicare. "Our medical system can't support every single person that comes through and says, 'Hey, I'm feeling 100 per cent well, can you test all my blood markers so I make sure I don't drop off to 90 per cent next week?" he says. "Doctors just don't have the capacity and time for that locally in Australia and fair enough — that's probably an area where longevity has really come into it."
